Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alefacept in de novo kidney transplant recipients
NCT00543569Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Feb 2008
- Primary completion
- Feb 2011
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of alefacept in kidney transplant rejection, sponsored by Astellas Pharma. Started Feb 2008; status: completed.
02
Drugs
alefacept
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00543569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00543569.